BPMC Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines Corporation

Logo korporat perusahaan Blueprint Medicines (BPMC)

Blueprint Medicines is building a closed-loop precision oncology ecosystem by linking clinics with its own treatment protocols. The target net income per share growth rate reflects the current consensus, where the value 196.50 determines the parameter status. Despite pressure from government programs and competition, the rapid success of Ayvakit is generating a powerful cash flow, bringing the company closer to stable profitability.

BPMC: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Blueprint Medicines Corp. 04.07.2022 - 02.08.2025

Rincian metrik keuangan lan pasar Blueprint Medicines Corp. (BPMC)

Analisis fundamental perusahaan:Blueprint Medicines Corp, BPMC
Produk merek Blueprint Medicines Corporation

For investors in Blueprint Medicines (BPMC), this indicator serves as a key tool for assessing future profitability through the lens of expected earnings per share. The modeled EPS growth for the next fiscal year is calculated as the percentage change in projected net income, which in the case of Blueprint Medicines (BPMC) confirms high margins driven by the premium positioning of Ayvakit and a lack of competitors in mastocytosis therapy.

Perusahaan pesaing

GMAB (Genmab Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep exelixis.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvalent (NUVL)|KYMR (Kymera) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IDYA (IDEAYA Biosciences Inc)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Enliven Pharma|ORIC Pharmaceuticals Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Prakiraan wutah bathi saben saham kanggo taun ngarep|TYRA: Proyeksi tambahing bathi saben saham ing taun ngarep|VSTM (verastem.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Monte Rosa Tx GLUE|Prakiraan wutah bathi kanggo taun ngarep CGEM|Immuneering - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|C4 Therapeutics - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BDTX|RPTX: Prakiraan wutah bathi saben saham kanggo taun ngarep|PMV Pharma - Proyeksi tambahing bathi saben saham ing taun ngarep|KPTI: Prakiraan wutah bathi kanggo taun ngarep|Propanc Biopharma Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|BGMS (Cyclacel) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep aadibio.com AADI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aileron Therapeutics Inc (ALRN)|GLYC (GlycoMimetics) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks Therapeutics, Inc)